Akèy › Leksemi biphenotipik egi › Texas › Fort Worth
Etid klinik pou Leksemi biphenotipik egi nan Fort Worth, TX
5 etid pou Leksemi biphenotipik egi ap chèche patisipan nan sit nan ak bò kote Fort Worth (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Ap rekriteFaz 2
- Cook Children's Medical Center, Fort Worth
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Ap rekriteFaz 3
- Cook Children's Medical Center, Fort Worth
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- Cook Children's Medical Center, Fort Worth
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Ap rekriteFaz 1
- Cook Children's Medical Center, Fort Worth
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Ap rekriteFaz 1
- Cook Children's Hospital, Fort Worth
Etid Leksemi biphenotipik egi nan lòt vil
- Seattle, WA15 etid
- Houston, TX11 etid
- New York City, NY10 etid
- Atlanta, GA9 etid
- Durham, NC8 etid
- Memphis, TN7 etid
- Chicago, IL7 etid
- Charlotte, NC6 etid
- Aurora, CO6 etid
- Baldwin Park, CA6 etid
- Portland, OR6 etid
- Los Angeles, CA6 etid
Lòt etid nan Fort Worth
- Kansè Poumon ki pa ti selil18 etid
- Kansè ovè17 etid
- Kansè Endomèt12 etid
- Kansè nan tete11 etid
- Kansè (tout kalite)9 etid
- Kansè pwostat9 etid
- Ensifizyans kadyak7 etid
- Kansè kolorektal7 etid
- Kansè tete negatif triple7 etid
- Kansè Metastatik7 etid
- Kansè renn (Kasinom selil renn)7 etid
- Kolit Ulseratif7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.